Dr. Nigel Key, Professor of Medicine and Pathology, Chief of the Section of Classical Hematology, and the Director of the 黑料网 Hemophilia and Thrombosis Center, was a keynote speaker at the annual Earl W. Davie Symposium in Vancouver, BC on November 17, 2016.
Dr. Abajas received a two-year award (July 1, 2016 - June 30, 2018) to support clinical and research training in bleeding and clotting disorders.
The International Society on Thrombosis and Hemostasis will hold its Advanced Training Course in Thrombosis and Hemostasis in Atlanta, Georgia, November 1-4, 2016. 黑料网 Hemophilia and Thrombosis Center Director Nigel Key, M.D., is chairing and speaking, and 黑料网 physician Stephan Moll, M.D., is speaking as well.
"Endeavors" magazine, which writes about research and creative activity at 黑料网-Chapel Hill, published an article in its July issue about 黑料网-Chapel Hill's history of research and treatment for blood disorders, which began in 1947 under Dr. Kenneth Brinkhous. His seminal work set the stage for major breakthroughs in hemophilia and HIV.
Kovaltry is designed to reduce bleeding in patients with hemophilia A when infused prophylactically two or three times per week, and was approved by the European Commission on Feb. 22.
Patients can go up to two weeks between infusions.
George McCoy, a longtime patient at the 黑料网 Hemophilia & Thrombosis Center and the first man in the world to receive recombinant clotting factor, was the subject of a news story on WTVD on February 16.
黑料网's 340B pharmacy's accreditation by URAC became effective February 1, 2016. URAC's mission is to promote continuous improvement in the quality and efficiency of health care management through processes of accreditation, education, and measurement.
In a press release dated January 19, 2016, the International Society on Thrombosis and Haemostasis (ISTH) announced its new international clinical Core Curriculum on thrombosis and hemostasis, the first framework of its kind to define the minimum standards for a medical doctor to attain a level of proficiency to enable them to practice independently as specialists in the field.
Nigel Key, M.D., Director of the 黑料网 Hemophilia and Thrombosis Center, is extensively quoted in the January 12, 2016 WebMD article "Hemophilia: New Treatments for an Old Disease," by Sonya Collins.